Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | JAK1 |
| Variant | A723D |
| Impact List | missense |
| Protein Effect | gain of function |
| Gene Variant Descriptions | JAK1 A723D lies within the protein kinase domain 1 of the Jak1 protein (UniProt.org). A723D results in constitutive phosphorylation of Jak1 and Stat5 in cell culture (PMID: 21393331, PMID: 24735922). |
| Associated Drug Resistance | |
| Category Variants Paths |
JAK1 mutant JAK1 act mut JAK1 A723D |
| Transcript | NM_002227.4 |
| gDNA | chr1:g.64844837G>T |
| cDNA | c.2168C>A |
| Protein | p.A723D |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_047419674.1 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321852 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321855.1 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001320923 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| XM_047419675.1 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_002227 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321856.2 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321855.2 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001320923.2 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321852.1 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321856 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321856.1 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321854.2 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321853.2 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321855 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001320923.1 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_002227.4 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321853.1 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_002227.3 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321852.2 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321854.1 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321854 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| NM_001321853 | chr1:g.64844837G>T | c.2168C>A | p.A723D | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| JAK1 A723D | cancer | sensitive | Ruxolitinib | Preclinical | Actionable | In a preclinical study, transformed cells harboring JAK1 A723D were sensitive to ATP-competitive JAK inhibitors, such as Jakafi (Ruxolitinib) (PMID: 21393331). | 21393331 |